Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Inflammatory Bowel Diseases

  Free Subscription


07.10.2019

1 Aliment Pharmacol Ther
1 Am J Gastroenterol
3 Eur J Gastroenterol Hepatol
1 Gastroenterology
1 Gut
12 Inflamm Bowel Dis
1 J Crohns Colitis
1 N Engl J Med
1 PLoS One
1 Scand J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. LUND K, Larsen MD, Knudsen T, Kjeldsen J, et al
    The impact of anti-TNFalpha therapy on colectomy rates and corticosteroid treatment among 3001 paediatric and adolescent patients with ulcerative colitis-a nationwide study from 1995 to 2015.
    Aliment Pharmacol Ther. 2019 Oct 3. doi: 10.1111/apt.15510.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  2. YANG DH, Park SJ, Kim HS, Park YS, et al
    High-Definition Chromoendoscopy Versus High-Definition White Light Colonoscopy for Neoplasia Surveillance in Ulcerative Colitis: A Randomized Controlled Trial.
    Am J Gastroenterol. 2019;114:1642-1648.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  3. SCHOENEFUSS F, Hoffmann P
    Serum gamma-globulin and albumin concentrations predict secondary loss of response to anti-TNFalpha in inflammatory bowel disease patients.
    Eur J Gastroenterol Hepatol. 2019 Sep 16. doi: 10.1097/MEG.0000000000001493.
    PubMed     Text format     Abstract available

  4. VIOLA A, Monterubbianesi R, Scalisi G, Furfaro F, et al
    Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study.
    Eur J Gastroenterol Hepatol. 2019;31:1361-1369.
    PubMed     Text format     Abstract available

  5. NAFTALI T, Bar-Lev Schleider L, Sklerovsky Benjaminov F, Lish I, et al
    Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects.
    Eur J Gastroenterol Hepatol. 2019;31:1376-1381.
    PubMed     Text format     Abstract available


    Gastroenterology

  6. DE BACKER E, Bode H, Baert F
    New onset diffuse parenchymal lung disease in a 52-year old female with ulcerative colitis.
    Gastroenterology. 2019 Sep 24. pii: S0016-5085(19)41353.
    PubMed     Text format    


    Gut

  7. LAMB CA, Kennedy NA, Raine T, Hendy PA, et al
    British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
    Gut. 2019 Sep 27. pii: gutjnl-2019-318484. doi: 10.1136/gutjnl-2019-318484.
    PubMed     Text format     Abstract available


    Inflamm Bowel Dis

  8. VAN DE VEN SEM, Derikx LAAP, Nagtegaal ID, van Herpen CM, et al
    Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk Factors.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574717. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. CLARKE WT, Papamichael K, Casteele NV, Germansky KA, et al
    Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational Study.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574728. doi: 10.1093.
    PubMed     Text format    

  10. CHIBA M, Nakane K, Abe H, Komatsu M, et al
    Onset of Ulcerative Colitis in a Patient with Nonalcoholic Fatty Liver Disease (NAFLD): Dramatic Effect of Plant-based Diet for NAFLD.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574851. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. NGUYEN GC, Low D, Chong RY, Diong C, et al
    Utilization of Diagnostic Imaging and Ionization Radiation Exposure Among an Inflammatory Bowel Disease Inception Cohort.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574895. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. ABU-SBEIH H, Wang Y
    Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574910. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. LONG MD, Smith TW, Dibonaventura M, Gruben D, et al
    Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574848. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. GIRON F, Pasto A, Tasciotti E, Abraham BP, et al
    Nanotechnology in the Treatment of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574918. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. DANILUK U, Daniluk J, Ciborowski M
    Reply to Letter to the Editor of Dr. Sitkin et al., Regarding "Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome is Another Key to the Pathogenesis of Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574842. doi: 10.1093.
    PubMed     Text format    

  16. SITKIN S, Demyanova E, Vakhitov T, Pokrotnieks J, et al
    Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome Is Another Key to the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574840. doi: 10.1093.
    PubMed     Text format    

  17. CHANDE N, Costello SP, Limketkai BN, Parker CE, et al
    Alternative and Complementary Approaches for the Treatment of Inflammatory Bowel Disease: Evidence From Cochrane Reviews.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574841. doi: 10.1093.
    PubMed     Text format    

  18. MOSER T, Bubel NE, Machegger L, Pikija S, et al
    Cerebral Vasculitis in Crohn's Disease: Always a Complication of Inflammatory Bowel Disease or Tumor Necrosis Factor-Alpha Inhibition?
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5574838. doi: 10.1093.
    PubMed     Text format    

  19. KELSEN JR, Conrad MA, Dawany N, Patel T, et al
    The Unique Disease Course of Children with Very Early onset-Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Sep 27. pii: 5575070. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  20. SMITH RL, Taylor KM, Friedman AB, Gibson RN, et al
    Systematic review: Clinical utility of gastrointestinal ultrasound in the diagnosis, assessment and management of patients with ulcerative colitis.
    J Crohns Colitis. 2019 Sep 28. pii: 5575710. doi: 10.1093.
    PubMed     Text format     Abstract available


    N Engl J Med

  21. LAI AR, Sheu L, Gensler LS, McQuaid K, et al
    A Terminal Event.
    N Engl J Med. 2019;381:970-976.
    PubMed     Text format    


    PLoS One

  22. DEURING JJ, Li M, Cao W, Chen S, et al
    Pregnane X receptor activation constrains mucosal NF-kappaB activity in active inflammatory bowel disease.
    PLoS One. 2019;14:e0221924.
    PubMed     Text format     Abstract available


    Scand J Gastroenterol

  23. AMCOFF K, Cao Y, Zhulina Y, Lampinen M, et al
    Prognostic significance of faecal eosinophil granule proteins in inflammatory bowel disease.
    Scand J Gastroenterol. 2019 Oct 2:1-8. doi: 10.1080/00365521.2019.1670251.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: